The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 15, 2022

Filed:

Jun. 14, 2019
Applicant:

Intarcia Therapeutics, Inc., Boston, MA (US);

Inventors:

Thomas R. Alessi, Hayward, CA (US);

Ryan D. Mercer, Dublin, CA (US);

Catherine M. Rohloff, Los Altos, CA (US);

Bing Yang, Redwood City, CA (US);

Assignee:

Intarcia Therapeutics, Inc., Boston, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/26 (2006.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 9/16 (2006.01); A61K 47/14 (2017.01); C07K 14/605 (2006.01); A61K 9/70 (2006.01); C07K 7/06 (2006.01); A61K 47/12 (2006.01); A61K 47/20 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01);
U.S. Cl.
CPC ...
A61K 38/26 (2013.01); A61K 9/0004 (2013.01); A61K 9/0024 (2013.01); A61K 9/10 (2013.01); A61K 9/1617 (2013.01); A61K 9/1623 (2013.01); A61K 9/7023 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/20 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); C07K 7/067 (2013.01); C07K 14/605 (2013.01); Y10T 29/494 (2015.01);
Abstract

A suspension formulation of an insulinotropic peptide (e.g., glucagon-like peptide-1 (GLP-1) or exenatide) is described. The suspension formulation comprises (i) a non-aqueous, single-phase vehicle, comprising one or more polymer and one or more one solvent, wherein the vehicle exhibits viscous fluid characteristics, and (ii) a particle formulation comprising the insulinotropic peptide, wherein the peptide is dispersed in the vehicle. The particle formulation further includes a stabilizing component comprising one or more stabilizers, for example, carbohydrates, antioxidants, amino acids, and buffers. Devices for delivering the suspension formulations and methods of use are also described.


Find Patent Forward Citations

Loading…